Pectopexy Autologous Vs Mesh

prospective comparative study describing using autologous graft for uterine- vault - cervical suspension vs mesh in treatment of apical prolapse

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Uterine Prolapse Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Pelvic Organ Prolapse Prolapse Urogenital Diseases Uterine Diseases Vault Prolapse, Vaginal

Age range

20 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Urogynecology Unit, Cairo, Cairo Governorate, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

uterine - vault prolapse

Exclusion criteria

previous vaginal repair for uterine or vaginal prolapse previous suspension procedures for apical prolapse

Treatment and study plan

pectopexy mesh

Procedure

pectopexy with mesh

pectopexy autologous

Procedure

pectopexy using autologous graft

Primary outcomes

POP-Q

Time frame: 3 month

assesment of degree of prolapse correction after surgery

Sponsors and collaborators

Lead sponsor

Ain Shams Maternity Hospital

Other

Collaborators

Armed forces hospital wadi aldwaser

Registry information

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Jul 29, 2024
Registry last updated: Nov 6, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed